What is the generic name?

FOSAMPRENAVIR CALCIUM

What is the Trade Name for FOSAMPRENAVIR CALCIUM?

LEXIVA

What are the Indications for FOSAMPRENAVIR CALCIUM?

• 1 INDICATIONS AND USAGE LEXIVA is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection. The following points should be considered when initiating therapy with LEXIVA plus ritonavir in protease inhibitor-experienced patients: ‚Ä¢ The protease inhibitor-experienced patient trial was not large enough to reach a definitive conclusion that LEXIVA plus ritonavir and lopinavir plus ritonavir are clinically equivalent [see Clinical Studies ( 14.2 )] . ‚Ä¢ Once-daily administration of LEXIVA plus ritonavir is not recommended for adult protease inhibitor-experienced patients or any pediatric patients [see Dosage and Administration ( 2.2 , 2.3 ), Clinical Studies ( 14.2 , 14.3 )] . ‚Ä¢ Dosing of LEXIVA plus ritonavir is not recommended for protease inhibitor-experienced pediatric patients younger than 6 months [see Clinical Pharmacology ( 12.3 )]. LEXIVA is an HIV protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. ( 1 )

References: https://open.fda.gov/